PANHEMATIN

recordati rare diseases canada inc🇨🇦 Health Canada

Approval Id: 1f720fc1ba7ffb0f
Drug Approval Canada Name: PANHEMATIN
Product Name: PANHEMATIN
Status: Marketed
Status Date: 2018-12-05
Original Market Date: 2018-12-05
Din: 02478765
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Atc Original: B06AB01 HEMATIN
Atc Name: b 06 ab 01
Aig Number: 0160470001
Company Name: recordati rare diseases canada inc
Company Address: 3080 Yonge Street, Suite 6060, Toronto, Ontario, Canada, M4N 3N1

HEMIN

268 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

1f720fc1ba7ffb0f

Type

Standard